Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Miyazaki

Showing results (211-220 of 217) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 217 results.
Molecular Genetics and Metabolism|March 23, 2021
Hypoxia ameliorates brain hyperoxia and NAD<sup>+</sup> deficiency in a murine model of Leigh syndromeRobert M H Grange, Rohit Sharma, Hardik Shah, et al.
Nitric Oxide : Biology and Chemistry|August 17, 2021
Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumoniaBijan Safaee Fakhr, Raffaele Di Fenza, Stefano Gianni, et al.
Obstetrics and Gynecology|August 28, 2020
High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19)Bijan Safaee Fakhr, Steffen B Wiegand, Riccardo Pinciroli, et al.
Rheumatology (Oxford, England)|November 7, 2023
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational studyKoshiro Sonomoto, Shingo Nakayamada, Yoshihisa Fujino, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 9, 2026
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational studyTakafumi Aritomi, Koshiro Sonomoto, Shingo Nakayamada, et al.
Nature Communications|May 26, 2021
Sulfide catabolism ameliorates hypoxic brain injuryEizo Marutani, Masanobu Morita, Shuichi Hirai, et al.
Arthritis Research & Therapy|March 19, 2026
Treatment patterns, treat-to-target goals and clinical outcomes of patients with active lupus nephritis: real-world evidence from a multicentre cohort studyJoanna Kent, Xiaomeng Xu, Arushi Ramnarain, et al.
Pageof 22

Showing results (211-220 of 217) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 217 results.
Molecular Genetics and Metabolism|March 23, 2021
Hypoxia ameliorates brain hyperoxia and NAD<sup>+</sup> deficiency in a murine model of Leigh syndromeRobert M H Grange, Rohit Sharma, Hardik Shah, et al.
Nitric Oxide : Biology and Chemistry|August 17, 2021
Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumoniaBijan Safaee Fakhr, Raffaele Di Fenza, Stefano Gianni, et al.
Obstetrics and Gynecology|August 28, 2020
High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19)Bijan Safaee Fakhr, Steffen B Wiegand, Riccardo Pinciroli, et al.
Rheumatology (Oxford, England)|November 7, 2023
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational studyKoshiro Sonomoto, Shingo Nakayamada, Yoshihisa Fujino, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 9, 2026
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational studyTakafumi Aritomi, Koshiro Sonomoto, Shingo Nakayamada, et al.
Nature Communications|May 26, 2021
Sulfide catabolism ameliorates hypoxic brain injuryEizo Marutani, Masanobu Morita, Shuichi Hirai, et al.
Arthritis Research & Therapy|March 19, 2026
Treatment patterns, treat-to-target goals and clinical outcomes of patients with active lupus nephritis: real-world evidence from a multicentre cohort studyJoanna Kent, Xiaomeng Xu, Arushi Ramnarain, et al.
Pageof 22